Kilitch Drugs India Ltd - 524500 - Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate
Intimation under Regulation 39 (3) of SEBI (Listing Obligation and Disclosure Requirements) Regulations, 201509-05-2019
09-05-2019
Kilitch Drugs India Ltd - 524500 - Outcome of Board Meeting
Outcome of Board Meeting held on May 3, 201903-05-2019
KILITCH DRUGS (INDIA) LTD. - 524500 - Board Meeting Intimation for To Consider The Allotment Of Equity Shares Pursuant To Exercise Of Option Granted To Employees Of The Company Under ESOS Scheme
KILITCH DRUGS (INDIA) LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 03/05/2019 ,inter alia, to consider and approve the allotment of Equity Shares pursuant to exercise of option granted to employees of the Company under ESOS Scheme25-04-2019
Kilitch Drugs India Ltd - 524500 - Compliance Certificate Under Regulation 40(9) Of The SEBI (LODR) Regulations, 2015 For The Quarter And Year Ended 31St March, 2019.
Compliance Certificate Under Regulation 40(9) Of The SEBI (LODR) Regulations, 2015 For The Quarter And Year Ended 31st March, 201925-04-2019
KILITCH DRUGS (INDIA) LTD. - 524500 - Format of Initial Disclosure to be made by an entity identified as a Large Corporate
Format of Initial Disclosure to be made by an entity identified as a Large Corporate. Sr. No. Particulars Details 1Name of CompayKILITCH DRUGS (INDIA) LTD. 2CININE729D01010 3 Outstanding borrowing of company as on 31st March / 31st December, as applicable (in Rs cr) 0 4Highest Credit Rating during the previous FY NA 4aName of the Credit Rating Agency issuing the Credit Rating mentioned in (4)Not Applicable 5Name of Stock Exchange# in which the fine shall be paid, in case of shortfall in the required borrowing under the frameworkBSE We confirm that we are a Large Corporate as per the applicability criteria given under the SEBI circular SEBI/HO/DDHS/CIR/P/2018/144 dated November 26, 2018. No Name of the Company Secretary: Harshal Anant Patil Designation: Company Secretary & Compliance Officer EmailId: harshalpatil@kilitch.com Name of the Chief Financial Officer: Sujit Kumar Dash Designation: Chief Financial Officer EmailId: sujitkumar@kilitch.com Date: 25/04/2019 Note: In terms para of 3.2(ii) of the circular, beginning F.Y 2022, in the event of shortfall in the mandatory borrowing through debt securities, a fine of 0.2% of the shortfall shall be levied by Stock Exchanges at the end of the two-year block period. Therefore, an entity identified as LC shall provide, in its initial disclosure for a financial year, the name of Stock Exchange to which it would pay the fine in case of shortfall in the mandatory borrowing through debt markets.25-04-2019
KILITCH DRUGS (INDIA) LTD. - 524500 - Compliances-Certificate under Reg. 54 (5) of SEBI (DP) Regulations, 1996
Certificate pursuant to Regulation 74(5) of SEBI (Depository and Participants) Regulations, 201820-04-2019
Kilitch Drugs India Ltd - 524500 - Compliance Certificate For The Period Ended March 31, 2019.
Compliance Certificate Of The Company As Per Regulation 7(3) Of SEBI (Listing Obligation And Disclosure Requirement) Regulations, 2015 For The Period Ended March 31, 2019.15-04-2019
Kilitch Drugs India Ltd - 524500 - Shareholding for the Period Ended March 31, 2019
Kilitch Drugs India Ltd has submitted to BSE the Shareholding Pattern for the Period Ended March 31, 2019. For more details, kindly Click here11-04-2019
KILITCH DRUGS (INDIA) LTD. - 524500 - Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate
Intimation under Regulation 39 (3) of SEBI (Listing Obligation and Disclosure Requirements) Regulations, 201510-04-2019
KILITCH DRUGS (INDIA) LTD. - 524500 - Statement Of Investor Complaints For The Quarter Ended March 2019
No.of Investor complaints pending at the beginning of the quarter No.of Investor complaints received during the quarter No.of Investor complaints disposed of during the quarter No.of Investor complaints unresolved at the end of the quarter 0101 Name of the Signatory :- Harshal PatilDesignation :- Company Secretary and Compliance Officer09-04-2019